Synklino is a series a startup based in Denmark. 1 investor tracked on Brouky Intelligence. Status: zombie. Data sourced from Brouky Intelligence.
About
Synklino is a biotechnology company developing first-in-class therapies to eliminate latent viral reservoirs in people with chronic viral infections, with an initial focus on Cytomegalovirus (CMV).
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky